» Articles » PMID: 28620645

Alloimmunity But Not Viral Immunity Promotes Allograft Loss in a Mouse Model of Polyomavirus-Associated Allograft Injury

Overview
Publisher Wolters Kluwer
Specialty General Surgery
Date 2017 Jun 17
PMID 28620645
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The interplay between viral infection and alloimmunity is known to influence the fate of transplanted organs. Clarifying how local virus-associated inflammation/injury and antiviral immunity can alter host alloimmune responses in transplantation remains a critical question.

Methods: We used a mouse model of polyomavirus (PyV) infection and kidney transplantation to investigate the roles of direct viral pathology, the antiviral immune response, and alloimmunity in the pathogenesis of PyV-associated allograft injury. We have previously shown that an effective primary T cell response is required in PyV-associated graft injury.

Results: Here we show that the transfer of primed antidonor, but not antiviral, T cells results in PyV-associated allograft injury. In further studies, we use a surrogate minor antigen model (ovalbumin) and show that only antidonor specific T cells and not antiviral specific T cells are sufficient to mediate injury. Lastly, we demonstrate that local but not systemic virus-mediated inflammation and injury within the graft itself are required.

Conclusions: These data suggest that in this mouse model, the predominant mechanism of allograft injury in PyV-associated injury is due to an augmented alloimmune T cell response driven by virus-induced inflammation/injury within the graft. These studies highlight the important interplay between viral infection and alloimmunity in a model system.

Citing Articles

Association between Respiratory Virus Infection and Development of Donor-Specific Antibody in Lung Transplant Recipients.

Nellore A, Houp J, Killian J, Limaye A, Fisher C Viruses. 2024; 16(10).

PMID: 39459908 PMC: 11512259. DOI: 10.3390/v16101574.


Polyomavirus Wakes Up and Chooses Neurovirulence.

Butic A, Spencer S, Shaheen S, Lukacher A Viruses. 2023; 15(10).

PMID: 37896889 PMC: 10612099. DOI: 10.3390/v15102112.

References
1.
Egli A, Binggeli S, Bodaghi S, Dumoulin A, Funk G, Khanna N . Cytomegalovirus and polyomavirus BK posttransplant. Nephrol Dial Transplant. 2007; 22 Suppl 8:viii72-viii82. DOI: 10.1093/ndt/gfm648. View

2.
Wiseman A . Polyomavirus nephropathy: a current perspective and clinical considerations. Am J Kidney Dis. 2009; 54(1):131-42. DOI: 10.1053/j.ajkd.2009.01.271. View

3.
Ehst B, Ingulli E, Jenkins M . Development of a novel transgenic mouse for the study of interactions between CD4 and CD8 T cells during graft rejection. Am J Transplant. 2003; 3(11):1355-62. DOI: 10.1046/j.1600-6135.2003.00246.x. View

4.
Rowe W . The epidemiology of mouse polyoma virus infection. Bacteriol Rev. 1961; 25:18-31. PMC: 441071. DOI: 10.1128/br.25.1.18-31.1961. View

5.
Kuypers D . Management of polyomavirus-associated nephropathy in renal transplant recipients. Nat Rev Nephrol. 2012; 8(7):390-402. DOI: 10.1038/nrneph.2012.64. View